Insights from New Research: Realizing Benefits of Digital Cognitive Assessments in Primary Care

Feb. 21, 2024
Uncover the latest research on digital cognitive assessments in primary care. Join neuropsychologists on February 21st for an insightful discussion on detecting Alzheimer's disease and other dementias, and enhancing patient care in ambulatory settings using digital assessment technology.

Date: Wednesday, February 21, 2024
Time: 1:00 PM ET / 12:00 PM CT / 10:00 AM PT / 6:00 PM GMT
Duration: 1 hour

Already registered? Click here to log in.


Alzheimer's disease remains without a cure, but recent advancements in medication have demonstrated the ability to slow its progression when administered in its early stages. As a result, it is becoming increasingly crucial for ambulatory primary and specialty care providers to identify patients at risk before the onset of significant symptoms.

Join us for a conversation with neuropsychologists Drs. David J. Libon and Rodney A. Swenson — moderated by Dr. John Showalter — about their recently published peer-reviewed research article, “Using digital assessment technology to detect neuropsychological problems in primary care settings.”

During the webinar, you’ll learn about:

  • The background and methods of the research, conducted with patients from the Rowan University, Department of Family Medicine and the New Jersey Institute for Successful Aging
  • The research results of implementing a digital assessment in ambulatory primary and specialty care
  • How a digital cognitive assessment could benefit your practice and enhance patient care


David J. Libon, PhD
New Jersey Institute for Successful Aging at Rowan University

Dr. Libon has conducted considerable research regarding neuropsychological syndromes associated with MRI evidence of white matter alterations and subcortical vascular dementia. Dr. Libon has published approximately 170 papers and edited two books, including a book on Edith Kaplan and the Boston Process Approach as related to clinical neuropsychological assessment. More recently, the Libon lab has used statistical modeling techniques to elucidate phenotypic syndromes in both dementia and mild cognitive impairment (MCI).

Rodney A. Swenson, PhD
Clinical Professor of Psychiatry and Behavioral Science
University of North Dakota School of Medicine and Health Sciences

Dr. Swenson is a board-certified Neuropsychologist who operates Neuropsychology Associates — serving adult patients and their families — and is a Clinical Professor at the University of North Dakota School of Medicine and Health Sciences. Dr. Swenson earned his doctoral degree from the University of North Dakota. He completed his fellowship in Neuropsychology at the Boston V.A. Medical Center, with appointments at the Boston University School of Medicine and Harvard, under the supervision of Dr. Edith Kaplan who is renowned for her critical role in establishing neuropsychology as a specialty area of study.

John Showalter, MD
Chief Product Officer
Linus Health

Dr. Showalter is the Chief Product Officer at Linus Health and a dual board-certified primary care physician. As the Chief Product Officer, he is responsible for the integrated strategy for the product, medical, and analytics teams. Prior to joining Linus Health, he spent five years as Chief Product Officer at Jvion, a leader in clinical AI. His experience also includes 10 years in health systems, most recently serving as CMIO and CHIO at the University of Mississippi Medical Center, where he also practiced clinically in family medicine.

Sponsored by